FDA GRAS Ingredient Discussions in Infant Formula Dossiers (2021–Present)

FDA GRAS Ingredient Discussions in Infant Formula Dossiers (2021–Present)

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request: From January 1st, 2021 onwards, any exchange on GRAS status of ingredients used in infant formula for the US market, that is not publicly available on the FDA GRN notification page, between the FDA and 1. infant formula manufacturers 2. infant formula ingredient manufacturers and 3. any third party acting on behalf of points 1 and 2. This could include but it not limited to, any pre-submission meetings, or meeting memos for 1. ingredients for use in infant formula that may or may not have had a GRN notification or 2. ingredients GRAS status as part of infant formula dossiers (either new infant formula dossiers, or amendment to existing infant formula dossiers).
Tags: Food, GRAS, 2021
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details